Anyone who has been involved in the process of creating a plain language summary understands the challenges it entails. How do you take a detailed document and translate it into a plain language summary understandable by lay readers and experts? How do you establish a process to create summaries of the right quality, on time and reliably?
In this free webinar, the featured speakers will focus on how the pharmaceutical industry is engaging with patients and patient advocates to gain feedback and produce high-quality plain language summaries. The job is not done with the finalization of the English plain language summary. Learn from the companies who have translated the plain language summaries about the common pitfalls and recommendations to avoid them.
At the end of this session, there will be an open question and answer session for the speakers to address any problems and challenges you face in plain language summary projects.
Debra Guerreiro, Associate Director, Plain Language Summary Program Lead, Janssen Data Transparency
Debra Guerreiro is the lead for the plain language summary initiative at Janssen R&D. She is responsible for the initiation, production, approval, translation and dissemination of aggregate clinical study results to Janssen study participants in compliance with regulatory authorities and other stakeholders. Debra has 15 years of diverse pharmaceutical experience in clinical research and project and resource management, holding positions at Merck & Co, Johnson & Johnson and Bristol Myers Squibb. She enjoyed 10 years of cross-industry experience in business consulting and clinical trial transparency at Kinapse, Inc. She founded WynBridge, LLC focused exclusively on providing clinical trial disclosure operational and advisory services to align sponsors with their legal and ethical responsibilities. She also served as project manager for TransCelerate Biopharma, Inc, responsible for delivering positions papers on the anonymization of clinical documents and de-identification of trial datasets and the return of results to study participants.Message Presenter
Dianne Beland, Senior Manager, Clinical Trial Data Sharing/Disclosure, Celgene Corporation
Dianne Beland has been in the pharmaceutical industry for over 20 years. She is a strong research professional skilled in writing plain language summaries of results for Phase I-IV clinical trials. She has extensive experience in clinical research, vendor management, oncology, hematology and investigator-initiated trials.Message Presenter
Jessica Valencia, PhD, Operational Excellence Expert, Novartis Pharmaceuticals, Patient Engagement & Advocacy
Jessica Valencia is an Operational Excellence Expert with over 15 years of pharmaceutical industry experience at Novartis. In her current role, she has developed the process for the creation of plain language trial summaries and other patient communications for clinical trials. She is also closely involved in writing these communications for early phase clinical trials. Jessica’s past experience includes preclinical drug discovery, clinical trial management, monitoring, medical writing, and process improvement. She has supported numerous clinical pharmacology and translational medicine studies and submissions across various therapeutic areas. In addition, Jessica has been responsible for process improvement, training, template creation and management related to protocol and clinical study report writing. She also gained extensive vendor management experience when she built and managed the external medical writing network for Translational Medicine at Novartis.Message Presenter
Vidhi Vashisht, Associate Director, Clinical Trial Disclosure, Development Operations, Kinapse, a Syneos Health Company
Vidhi Vashisht leads plain language summary services at Kinapse and is the subject matter expert for plain language summaries and clinical trial disclosure (CTD). She has over eight years of experience in clinical research and clinical trial disclosure. She is passionate about bringing clinical research information to the patients, their families and the public. She has experience across varied therapy areas and all phases of clinical research.
She holds a Master of Science (Pharmacy) degree with a specialty in medicinal chemistry.Message Presenter
Who Should Attend?
This webinar is suitable for senior professionals who are:
- Working in the clinical trial transparency or medical writing domain
- Responsible to produce, review and/or approve plain language summaries
- Establishing processes for plain language summaries
What You Will Learn
Participants will gain insights into:
- Benefits of engaging with patients and/or patient advocates when producing high quality PLSs
- Common pitfalls in translating PLSs and benefits of incorporating a linguistic review to avoid them
Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com.